Syncromune® Inc. to Present Initial Clinical Data from SYNC-T SV-102 Phase 1 as a Late-Breaker at the American Association for Cancer Research Annual Meeting 2024

Syncromune® Inc. to Present Initial Clinical Data from SYNC-T™ SV-102 Phase 1 as a Late-Breaker at the American Association for Cancer Research Annual Meeting 2024Presentation will take place during the “Cancer Vaccines: Ready for Prime Time?” session onApril 7, from 3:00 - 5:00pm PT at the San Diego Convention CenterMarch...

2919 E. Commercial Blvd.
Fort Lauderdale, FL 33308

Syncromune™ © 2023   ·   Terms of Use   |   Privacy   |   Cookies